Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  536 results for ""COAGULANTS""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Biological mechanisms underlying inter-individual variation in factor VIII clearance in haemophilia.

Subjects: Coagulants/Coagulants/Coagulants/*pharmacokinetics ; Factor VIII/Factor VIII/Factor VIII/*pharmacokinetics ; Hemophilia A/Hemophilia A/Hemophilia A/*drug therapy

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2020 Jul; Vol. 26 (4), pp. 575-583. Date of Electronic Publication: 2020 Jun 28.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

FVIII dosages in persons with haemophilia A treated with extended half-life products: From local biology to optimized patient management.

  • Authors : Perrier-Cornet A; Service d'Hématologie Biologique, Centre Hospitalier Universitaire Bicêtre, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, France.; Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

Subjects: Coagulants/Coagulants/Coagulants/*therapeutic use ; Factor VIII/Factor VIII/Factor VIII/*therapeutic use ; Hemophilia A/Hemophilia A/Hemophilia A/*drug therapy

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2019 Nov; Vol. 25 (6), pp. e361-e363. Date of Electronic Publication: 2019 Jun 17.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data.

  • Authors : Eichler H; Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University and University Hospital, Homburg/Saar, Germany.; Angchaisuksiri P

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Coagulants/Coagulants/Coagulants/*therapeutic use ; Hemophilia A/Hemophilia A/Hemophilia A/*drug therapy

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2019 Jan; Vol. 25 (1), pp. 60-66. Date of Electronic Publication: 2018 Nov 08.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective.

  • Authors : Lorenzoni V; Institute of Management, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà n. 33, Pisa, Italy.; Triulzi I

Subjects: Coagulants/Coagulants/Coagulants/*therapeutic use ; Factor VIII/Factor VIII/Factor VIII/*therapeutic use ; Hemophilia A/Hemophilia A/Hemophilia A/*therapy

  • Source: BMC health services research [BMC Health Serv Res] 2018 Aug 02; Vol. 18 (1), pp. 596. Date of Electronic Publication: 2018 Aug 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963

Record details

×
Editorial & Opinion

The importance of ABO blood group in pharmacokinetic studies in haemophilia A.

  • Authors : Franchini M; Department of Hematology and Transfusion Medicine, 'Carlo Poma' Hospital, Mantua, Italy.; Mengoli C

Subjects: ABO Blood-Group System* ; Hemostasis*; Coagulants/Coagulants/Coagulants/*pharmacokinetics

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2018 May; Vol. 24 (3), pp. e122-e123. Date of Electronic Publication: 2018 Feb 08.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Outcome of Surgical Management of Hemophilic Pseudotumor: Review of 10 Cases from Single-Center.

  • Authors : Yao YF; Department of Orthopaedic Surgery, Second Affiliated Hospital of Anhui Medical University, Heifei, China.; Gao Q

Subjects: Bone Diseases/Bone Diseases/Bone Diseases/*surgery ; Hemophilia A/Hemophilia A/Hemophilia A/*complications; Adult

  • Source: Orthopaedic surgery [Orthop Surg] 2022 Jan; Vol. 14 (1), pp. 27-34. Date of Electronic Publication: 2021 Nov 28.Publisher: Wiley on behalf of the Chinese Orthopedic Association Country of Publication: Australia NLM ID: 101501666 Publication Model: Print-Electronic

Record details

×
Academic Journal

Assessment of Relative Bioavailability of Moroctocog Alfa and Moroctocog Alfa (AF-CC) in Subjects With Severe Hemophilia A.

Subjects: Coagulants/Coagulants/Coagulants/*pharmacokinetics ; Factor VIII/Factor VIII/Factor VIII/*pharmacokinetics ; Hemophilia A/Hemophilia A/Hemophilia A/*drug therapy

  • Source: Clinical and translational science [Clin Transl Sci] 2018 May; Vol. 11 (3), pp. 283-288. Date of Electronic Publication: 2018 Mar 25.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Minimally invasive surgery for haemophilic pseudotumour of the limbs: 28 years of experience.

  • Authors : Caviglia HA; Department of Orthopaedics and Traumatology, General Hospital Dr. Juan A. Fernández, Buenos Aires, Argentina.; Haemophilia Foundation, Buenos Aires, Argentina.

Subjects: Extremities/Extremities/Extremities/*pathology ; Hematoma/Hematoma/Hematoma/*surgery ; Hemophilia A/Hemophilia A/Hemophilia A/*pathology

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2020 Jul; Vol. 26 (4), pp. 694-700. Date of Electronic Publication: 2020 Jun 12.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

FVIII/VWF complex displays a greater pro-haemostatic activity than FVIII preparations devoid of VWF: Study in plasma and cell-based models.

  • Authors : Ammollo CT; Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy.; Semeraro F

Subjects: Factor VIII/Factor VIII/Factor VIII/*pharmacology ; Hemophilia A/Hemophilia A/Hemophilia A/*drug therapy ; von Willebrand Factor/von Willebrand Factor/von Willebrand Factor/*pharmacology

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2020 Jul; Vol. 26 (4), pp. e151-e160. Date of Electronic Publication: 2020 Apr 23.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and safety of BAY 81-8973, a full-length recombinant factor VIII: results from the LEOPOLD I trial.

  • Authors : Saxena K; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. .; Lalezari S

Subjects: Coagulants/Coagulants/Coagulants/*therapeutic use ; Factor VIII/Factor VIII/Factor VIII/*therapeutic use ; Hemophilia A/Hemophilia A/Hemophilia A/*drug therapy

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2016 Sep; Vol. 22 (5), pp. 706-12. Date of Electronic Publication: 2016 Jun 24.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  536 results for ""COAGULANTS""